Development and validation of a liquid chromatographic/tandem mass spectrometric method for the determination of sertraline in human plasma

Rapid Communications in Mass Spectrometry
2006.0

Abstract

<jats:title>Abstract</jats:title><jats:p>A sensitive and rapid liquid chromatographic/tandem mass spectrometric method was developed and validated for the determination of sertraline in human plasma. The analyte and internal standard (IS, diphenhydramine) were extracted with 3 mL of diethyl ether/dichloromethane (2:1, v/v) from 0.25 mL plasma, then separated on a Zorbax Eclipse XDB C<jats:sub>18</jats:sub> column using methanol/water/formic acid (75:25:0.1, v/v/v) as the mobile phase. The triple quadrupole mass spectrometry was applied via an atmospheric pressure chemical ionization (APCI) source for detection. The fragmentation pattern of the protonated sertraline was elucidated with the aid of product mass spectra of isotopologous peaks. Quantification was performed using selected reaction monitoring of the transitions of <jats:italic>m/z</jats:italic> 306 → 159 for sertraline and <jats:italic>m/z</jats:italic> 256 → 167 for the IS. The method was linear over the concentration range of 0.10–100 ng/mL. The intra‐day and inter‐day precisions, expressed by relative standard deviation, were both less than 6.7%. Assay accuracies were within ±6.9% as terms of relative error. The lower limit of quantification (LLOQ) was identifiable and reproducible at 0.10 ng/mL with a precision of 8.3% and an accuracy of 9.6%. The validated method has been successfully applied for the pharmacokinetic study and bioequivalence evaluation of sertraline in 18 healthy volunteers after a single oral administration of 50 mg sertraline hydrochloride tablets. Copyright © 2006 John Wiley &amp; Sons, Ltd.

Knowledge Graph

Similar Paper

Development and validation of a liquid chromatographic/tandem mass spectrometric method for the determination of sertraline in human plasma
Rapid Communications in Mass Spectrometry 2006.0
High-performance liquid chromatography method for the quantification of pantoprazole in human plasma
Journal of Chromatography B 2005.0
Determination of berberine in human plasma by liquid chromatography–electrospray ionization–mass spectrometry
Journal of Pharmaceutical and Biomedical Analysis 2007.0
Liquid chromatography–tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma
Journal of Chromatography B 2022.0
Determination of gestrinone in human serum by liquid chromatography–electrospray tandem mass spectrometry
Journal of Chromatography B: Biomedical Sciences and Applications 2000.0
A validated UHPLC-MS/MS method for measurement of pharmacokinetics and tissue distribution of trolline in rat
Journal of Pharmaceutical and Biomedical Analysis 2019.0
LC–MS determination and bioavailability study of loperamide hydrochloride after oral administration of loperamide capsule in human volunteers
Journal of Pharmaceutical and Biomedical Analysis 2004.0
Quantitative analysis of Variolin analog (PM01218) in mouse and rat plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry
Journal of Chromatography B 2006.0
Development, Validation, and Routine Application of a High-Performance Liquid Chromatography Method Coupled with a Single Mass Detector for Quantification of Itraconazole, Voriconazole, and Posaconazole in Human Plasma
Antimicrobial Agents and Chemotherapy 2010.0
Establishment of LC-MS/MS method for determination of aloperine in rat plasma and its application in preclinical pharmacokinetics
Journal of Chromatography B 2021.0